Vidwan-ID : 292462



  • Prof Gita Chawla

  • Professor
  • Jamia Hamdard
Publications 1994 - 2019

Publications

  • 29
    Journal Articles
  • 2
    Review
  • 1
    Projects
  • 1
  • 6

Citations / H-Index

60 Citations
5 h-index
45 Citations

Altmetrics

1
1
1
6
1

Co-author Network


Expertise

Medicinal Chemistry

Working as Professor (Pharmaceutical Chemistry), School of Pharmaceutical Education and Research, Jamia Hamdard (Deemed to be University), New Delhi, India. About 27 years of teaching and research experience. Research Interest- • Synthetic medicinal chemistry and Pharmaceutical analysis • Design and synthesis of bioactive molecules with special reference to heterocyclic moieties in the field of anti-inflammatory, antimicrobial, antidepressant, antianxiety and antidiabetic activities.

Personal Information

Prof Gita Chawla

Female
Department of Pharmaceutical Chemistry, SPER Jamia Hamdard
Delhi, Delhi, India - 110062


Experience

  • Professor

    Department of Pharmaceutical Chemistry

    Jamia Hamdard


Qualification

  • PhD

    Jamia Hamdard

  • M.Pharm.

    University of Delhi

  • B.Pharm.

    University of Delhi


Membership In Professional Bodies

Indian Pharmacy Graduates' Association

Life membership

Association of Pharmaceutical Teachers of India

Life membership

Asian Polymer Association

Life membership

Read More

Indian Pharmacy Graduates' Association

Life membership

Association of Pharmaceutical Teachers of India

Life membership

Asian Polymer Association

Life membership

Indian society of analytical scientists (Delhi chapter)

Life membership

society of pharmacognosy

Life membership

Indian Society for Technical Education

Life membership

Read Less

Research Projects

Development of some novel thiazolidine-4-one analogs as potential PPAR-γ agonists for the treatment of Type 2 diabetes: in silico studies, synthesis and biological evaluation

Funding Agency : SERB, DST,India

Development of some novel thiazolidine-4-one analogs as potential PPAR-γ agonists for the treatment of Type 2 diabetes: in silico studies, synthesis and biological evaluation

Funding Agency : SERB, DST,India

Read Less